Comparison of CT/MRI-CEUS and US-CEUS fusion imaging techniques in the assessment of the thermal ablation of liver tumors

References

• Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;10:761–780.
   Google Scholar
• Minami Y, Nishida N, Kudo M. Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI. World J Gastroenterol. 2014;20:4160–4166.
   PubMed Web of Science ®Google Scholar
• Minami Y, Kudo M. Imaging modalities for assessment of treatment response to nonsurgical hepatocellular carcinoma therapy: contrast-enhanced US, CT, and MRI. Liver Cancer. 2015;4:106–114.
   PubMed Web of Science ®Google Scholar
• Du J, Li HL, Zhai B, et al. Radiofrequency ablation for hepatocellular carcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in guiding and assessing early therapeutic response and short-term follow-up results. Ultrasound Med Biol. 2015;41:2400–2411.
   PubMed Web of Science ®Google Scholar
• Kim CK, Choi D, Lim HK, et al. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: Utility of contrast-enhanced agent detection imaging. Eur J Radiol. 2005;56:66–73.
   PubMed Web of Science ®Google Scholar
• Claudon M, Dietrich CF, Choi BI, et al. World Federation for Ultrasound in Medicine; European Federation of Societies for Ultrasound: Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Der Medizin. 2013;39:187–210.
   Google Scholar
• Leyendecker JR, Dodd GD, Halff GA, et al. Sonographically observed echogenic response during intraoperative radiofrequency ablation of cirrhotic livers: pathologic correlation. Ajr Am J Roentgenol. 2002;178:1147–1151.
   PubMed Web of Science ®Google Scholar
• Zhou P, Kudo M, Minami Y, et al. What is the best time to evaluate treatment response after radiofrequency ablation of hepatocellular carcinoma using contrast-enhanced sonography? Oncology. 2007;72:92–97.
   PubMed Web of Science ®Google Scholar
• Wang X, Sofocleous CT, Erinjeri JP, et al. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases. Cardiovasc Intervent Radiol. 2013;36:166–175.
   PubMed Web of Science ®Google Scholar
• Lee MW. Fusion imaging of real-time ultrasonography with CT or MRI for hepatic intervention. Ultrasonography. 2014;33:227–239.
   PubMedGoogle Scholar
• Makino Y, Imai Y, Igura T, et al. Usefulness of the multimodality fusion imaging for the diagnosis and treatment of hepatocellular carcinoma. Dig Dis. 2012;30:580–587.
   PubMed Web of Science ®Google Scholar
• Toshikuni N, Tsutsumi M, Takuma Y, et al. Real-time image fusion for successful percutaneous radiofrequency ablation of hepatocellular carcinoma. J Ultrasound Med. 2014;33:2005–2010.
   PubMed Web of Science ®Google Scholar
• Wood BJ, Kruecker J, Abi-Jaoudeh N, et al. Navigation systems for ablation. J Vasc Interv Radiol. 2010;21:S257–S263.
   PubMed Web of Science ®Google Scholar
• Lee MW, Rhim H, Cha DI, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography. AJR Am J Roentgenol. 2012;198:1438–1444.
   PubMed Web of Science ®Google Scholar
• Krücker J, Xu S, Venkatesan A, et al. Clinical utility of real-time fusion guidance for biopsy and ablation. J Vasc Interv Radiol. 2011;22:515–524.
   PubMed Web of Science ®Google Scholar
• Zhong-Zhen S, Kai L, Rong-Qin Z, et al. A feasibility study for determining ablative margin with 3D-CEUS-CT/MR image fusion after radiofrequency ablation of hepatocellular carcinoma. Ultraschall in Med. 2012;33:E250–E225.
   PubMedGoogle Scholar
• Park HJ, Lee MW, Lee MH, et al. Fusion imaging-guided percutaneous biopsy of focal hepatic lesions with poor conspicuity on conventional sonography. J Ultrasound Med. 2013;32:1557–1564.
   PubMed Web of Science ®Google Scholar
• Makino Y, Imai Y, Igura T, et al. Feasibility of extracted-overlay fusion imaging for intraoperative treatment evaluation of radiofrequency ablation for hepatocellular carcinoma. Liver Cancer. 2016;5:269–279.
   PubMed Web of Science ®Google Scholar
• Ahn SJ, Lee JM, Lee DH, et al. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma. J Hepatol. 2017;66:347–354.
   PubMed Web of Science ®Google Scholar
• Mauri G, Cova L, De Beni S, et al. Real-time US-CT/MRI image fusion for guidance of thermal ablation of liver tumors undetectable with US: results in 295 cases. Cardiovasc Intervent Radiol. 2015;38:143–151.
   PubMed Web of Science ®Google Scholar
• Li K, Su Z, Xu E, et al. Evaluation of the ablation margin of hepatocellular carcinoma using CEUS-CT/MR image fusion in a phantom model and in patients. BMC Cancer. 2017;17:61.
   PubMed Web of Science ®Google Scholar
• Li K, Su ZZ, Xu EJ, et al. Improvement of ablative margins by the intraoperative use of CEUS-CT/MR image fusion in hepatocellular carcinoma. BMC Cancer. 2016;16:9.
   PubMed Web of Science ®Google Scholar
• Hiraoka A, Hirooka M, Koizumi Y, et al. A modified novel technique for determining therapeutic response to radiofrequency ablation therapy for hepatocellular carcinoma using US-volume system. Gastroenterology. 2010;23:493–497.
   Google Scholar
• Minami Y, Minami T, Chishina H, et al. US-US fusion imaging in radiofrequency ablation for liver metastases. Dig Dis. 2016;34:687–691.
   PubMed Web of Science ®Google Scholar
• Toshikuni N, Shiroeda H, Ozaki K, et al. Advanced ultrasonography technologies to assess the effects of radiofrequency ablation on hepatocellular carcinoma. Radiol Oncol. 2013;47:224–229.
   PubMed Web of Science ®Google Scholar
• Park HJ, Lee MW, Rhim H, et al. Percutaneous ultrasonography-guided radiofrequency ablation of hepatocellular carcinomas: usefulness of image fusion with three-dimensional ultrasonography. Clin Radiol. 2015;70:387–394.
   PubMed Web of Science ®Google Scholar
• Xu EJ, Lv SM, Li K, et al. Immediate evaluation and guidance of liver cancer thermal ablation by three-dimensional ultrasound/contrast-enhanced ultrasound fusion imaging. Int J Hyperthermia. 2018;34:870–876.
   PubMed Web of Science ®Google Scholar
• The Ministry of Health of The People’s Republic of China. Diagnosis and therapy criterion for hepatocellular carcinoma (version 2011). Chin Clin Oncol. 2011;2011:929–946.
   Google Scholar
• Lee MW, Rhim H, Cha DI, et al. Planning US for percutaneous radiofrequency ablation of small hepatocellular carcinomas (1-3 cm): value of fusion imaging with conventional US and CT/MR images. J Vasc Interv Radiol. 2013;24:958–965.
   PubMed Web of Science ®Google Scholar
• Konopke R, Bunk A, Kersting S. The role of contrast-enhanced ultrasound for focal liver lesion detection: an overview. Ultrasound Med Biol. 2007;33:1515–1526.
   PubMed Web of Science ®Google Scholar
• Lee MW, Kim YJ, Park HS, et al. Targeted sonography for small hepatocellular carcinoma discovered by CT or MRI: factors affecting sonographic detection. AJR Am J Roentgenol. 2010;194:W396–W400.
   PubMed Web of Science ®Google Scholar